Antibodies to pneumococcal polysaccharides in human milk: Lack of relationship to colonization and acute otitis media

Pediatric Infectious Disease Journal

Volumn 15, Issue 6, 1996, Pages 498-507

  Rosen, I Andersson V ^a   Hakansson A ^a   Aniansson, G ^a   Hansson, C ^a   Andersson, B ^b   Nylen O ^c   Sabharwal, H ^a   Svanborg, C ^a  

^a LUND UNIVERSITY   (Sweden)

^b Department of Clinical Immunology ^*  (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

acute otitis media; C polysaccharide; capsular polysaccharides; IgA antibodies; nasopharyngeal colonization; phosphorylcholine; Streptococcus pneumoniae

Indexed keywords

PHOSPHORYLCHOLINE; PNEUMOCOCCUS POLYSACCHARIDE;

ANTIGEN ANTIBODY REACTION; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; DISEASE ASSOCIATION; ENZYME ACTIVITY; HUMAN; INFANT; INFECTION RISK; MILK LEVEL; OTITIS MEDIA; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

ADULT; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL CAPSULES; BREAST FEEDING; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MILK; NASOPHARYNGEAL DISEASES; OTITIS MEDIA; PHOSPHORYLCHOLINE; POLYSACCHARIDES, BACTERIAL; STREPTOCOCCUS PNEUMONIAE;

EID: 0006366581     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199606000-00006     Document Type: Article

References (55)

1. Austrian R. Prevention of pneumococcal infection by immunization with capsular polysaccharides of Streptococcus pneumoniae: current status of polyvalent vaccines. J Infect Dis 1977;136(Suppl):S38-42.
2. LaForce FM. Pneumococcal vaccine: an emerging consensus. Ann Intern Med 1988;108:757-9.
3. Mäkelä PH, Sibakov M, Herva E, et al. Pneumococcal vaccine and otitis media. Lancet 1980;13:547-51.
4. Robbins JB. Vaccines for the prevention of encapsulated bacterial diseases: current status, problems and prospects for the future. Immunochemistry 1978;15:839-54.
5. Briles D, Forman C, Hudak S, Claflin J. Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae. J Exp Med 1982;156:1177-85.
6. Musher DM, Chapman AJ, Goree A, Jonsson S, Briles D, Baughn RE. Natural and vaccine-related immunity to Streptococcus pneumoniae. J Infect Dis 1986;154:245-56.
7. Dochez A, Avery O. The elaboration of a specific soluble substance by pneumococcus during growth. J Exp Med 1917;26:477-93.
8. How M, Brimacombe J, Stacey M. The pneumococcal polysaccharides. In: Wolfram M, ed. Advances in carbohydrate chemistry and biochemistry. New York: Academic, 1964:303-58.
9. Lee CJ. Bacterial capsular polysaecharides: biochemistry, immunity and vaccines. Mol Immunol 1987;24:1005-19.
10. Lund E, Henrichsen J. Laboratory diagnosis, serology and epidemiology of Streptococcus pneumoniae. In: Bergan T, Norris J, eds. Methods in microbiology. New York: Academic, 1978:242-62.
11. Johnston RJ. The host response to invasion by Streptococcus pneumoniae: protection and the pathogenesis of tissue damage. Rev Infect Dis 1981;3:282-8.
12. Kamme C, Agerberg M, Lundgren K. Distribution of Diplococcus pneumoniae types in acute otitis media in children and influence of the types on the clinical course in penicillin V therapy. J Infect Dis 1970;2:183-90.
13. Austrian R, Howie V, Ploussard J. The bacteriology of pneumococcal otitis media. John Hopkins Med J 1977;141:104-11.
14. Long S, Henretig F, Teter M, McGowan K. Nasopharyngeal flora and acute otitis media. Infect Immun 1983;41:987-91.
15. Gray BM, Converse GM III, Dillon HC, Jr. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis 1980;142:923-33.
16. Tomasz A. Choline in the cell wall of a bacterium: a novel type of polymer-linked choline in pneumococcus. Science 1967;157:694-7.
17. Brundish D, Baddiley J. Pneumococcal C-substance, a ribitol teichoic acid containing choline phosphate. Biochem J 1968;110:573-82.
18. Briles E, Tomasz T. Pneumococcal Forssman antigen. J Biol Chem 1973;248:6394-7.
19. Jennings HJ, Lugowski C, Young NM. Structure of the complex polysaccharide C-substance from Streptococcus pneumoniae type 1. Biochemistry 1980;19:4712-9.
20. Szu SC, Clarke S, Robbins JB. Protection against pneumococcal infection in mice conferred by phosphocholine binding antibodies: specificity of the phosphocholine binding and relation to several types. Infect Immun 1983;39:993-9.
21. Briles DE, Forman C, Crain M. Mouse antibody to phosphocholine can protect mice from infection with mouse-virulent human isolates of Streptococcus pneumoniae. Infect Immun 1992;60:1957-62.
22. Glass RI, Svennerhohn AM, Stoll BJ, et al. Protection against cholera in breast-fed children by antibodies in breast milk. N Engl J Med 1983;308:1389.
23. Svanborg-Edén C, Carlsson B, Hanson LÅ, et al. Anti-pili antibodies in breast milk. Lancet 1979;2:1245.
24. Mouton RP, Stoop JW, Ballieux RE, Mul NAJ. Pneumococcal antibodies in IgA of serum and external secretions. Clin Exp Immunol 1970;7:201-10.
25. Kassim OO, Raphael DH, Ako-Nai AK, Taiwo O, Torimmo SE, Afolasi OO. Class-specific antibodies to Bordetella pertussis, Haemophilus influenzae type b, Streptococcus pneumoniae and Neisseria meningitidis in human breast milk and maternal infant sera. Ann Trop Paediatr 1989;9:226-32.
26. Hanson LÅ, Ahlstedt S, Andersson B, et al. Protective factors in milk and the development of the immune system. Pediatrics 1985;75(Suppl.):172-6.
27. Mata LJ. The importance of breast-feeding for optimal child health and well being. Man Clin Mutat 1984;Suppl. 3:28-33.
28. Aniansson G, Alm B, Andersson B, et al. Nasopharyngeal colonization during the first year of life. J Infect Dis 1992;165:38-42.
29. Kauppi M, Saarinen L, Käyhty H. Anti-capsular polysaccharide antibodies reduce nasopharyngeal colonization by Haemophilus influenzae type b in infant rats. J Infect Dis 1993;167:365-71.
30. Aniansson G, Aim B, Andersson B, et al. A prospective cohort study on breast-feeding and otitis media in Swedish infants. Pediatr Infect Dis J 1994;13:183-8.
31. Austrian R. The Quellung reaction, a neglected microbiologic technique. Mt Sinai J Med 1976;43:669-709.
32. Henrichsen J. The pneumococcal typing system and pneumococcal surveillance. J Infect 1979;1:S31-7.
33. Pedersen FK, Henrichsen J. Detection of antibodies to pneumococcal capsular polysaccharides by enzyme-linked immunosorbent assay. J Clin Microbiol 1982;15:372-8.
34. Chesebro B, Metzger H. Affinity labeling of a phosphorylcholine binding mouse myeloma. Protein Biochem 1972;11:766-71.
35. Claflin JL, Lieberman R, Davie JM. Clonal nature of the immune response to phosphorylcholine I: specificity, class and idiotype of uniformity of phosphorylcholine-binding receptors on lymphoid cells. J Exp Med 1974;139:58-73.
36. Loda FA, Collier AM, Glezen WP, et al. Occurrence of Diplococcus pneumoniae in the upper respiratory tract of children. J Pediatr 1975;87:1087-93.
37. Klein J. The epidemiology of pneumococcal disease in infants and children. Rev Infect Dis 1981;3:246-53.
38. Loutonen J, Herva E, Karma P, Timonen M, Leinenen M, Mäkelä PH. The bacteriology of acute otitis media in children with special reference to Streptococcus pneumoniae as studied by bacteriological and antigen detection methods. Scand J Infect Dis 1981;13:177-83.
39. Pukander J, Karma P, Sipilä M. Occurrence and recurrence of acute otitis media among children. Acta Otolaryngol (Stockh) 1982;94:479-86.
40. Brimblecombe F, Cruickshank R, Masters P, Reid D, Stewart G. Family studies of respiratory infections. Br Med J 1958;1:119-28.
41. Sutliff W, Davies J. A study of the origin of naturally occurring immune bodies for pneumococci in infants. J Immunol 1937;32:43-8.
42. Kalin M, Lindberg AA. Distribution of pneumococcal types in the Stockhohn region 1976-1978. Scand J Infect Dis 1986;12:91-5.
43. Masters PL, Brumfitt W, Mendez RL, Likar M. Bacterial flora of the upper respiratory tract in Paddington families, 1952-4. Br Med J 1958;1:1200-5.
44. Dowling JN, Sheehe PR, Feldman HA. Pharyngeal pneumococcal acquisitions in "normal" families: a longitudinal study. J Infect Dis 1971;124:9-17.
45. Henderson FW, Collier AM, Sanyal MA, et al. A longitudinal study of respiratory viruses and bacteria in the etiology of acute otitis media with effusion. N Engl J Med 1982;306:1377-83.
46. Ruuskanen O, Arola M, Putto-Laurila A, et al. Acute otitis media and respiratory virus infection. Pediatr Infect Dis J 1989;8:94-9.
47. Ruuskanen O, et al. Viruses in acute otitis media: increasing evidence for clinical significance. Pediatr Infect Dis J 1991;10:425-7.
48. Ruuskanen O, Heikkinen T. Viral-bacterial interactions in acute otitis media. Pediatr Infect Dis J 1994;123:1047-9.
49. Klein B, Dollete F, Yolken R. The role of respiratory syncytial virus and other viral pathogens in acute otitis media. J Pediatr 1982;101:16-20.
50. Gwaltney JMJ, Sande MA, Austrian R, Hendley JO. Spread of Streptococcus pneumoniae in families: II. Relation of transfer of S. pneumoniae to incidence of colds and serum antibody. J Infect Dis 1975;132:62-8.
51. Chonmaitree T, Owen MJ, Howie VM. Respiratory viruses interfere with bacteriologic response to antibiotics in children with acute otitis media. J Infect Dis 1990;162:546-9.
52. Chonmaitree T, Owen MJ, Patel JA, et al. Effect of viral respiratory tract infection on outcome of acute otits media. J Pediatr 1992;120:856-62.
53. Håkansson A, Kidd A, Wadell G, Sabharwal H, Svanborg C. Adenovirus infection enhances in vitro adherence of Streptococcus pneumoniae. Infect Immun 1994;62:2707-14.
54. Löfström G. Nonspecific capsular swelling in pneumococci: a serologic and clinical study. Acta Med Scand 1943; 141(Suppl.):1-98.
55. Takala AK, Eskola J, Leinenen M, et al. Reduction of oropharyngeal carnage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J Infect Dis 1991;164:982-6.